CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor

Tyler Funnell(United States Geological Survey), Samuel Aparício(BC Cancer Agency), Shinya Tasaki(Rush University Medical Center), Masatoshi Karashima(Takeda (Japan)), Nao Morishita(Takeda (Japan)), Tomohiro Ohashi(Takeda (Japan)), Noriko Uchiyama(Takeda (Japan)), Hiroyoshi Toyoshiba(Tokyo Health Care University), Sohrab P. Shah(Memorial Sloan Kettering Cancer Center), Adrian Wan(University of British Columbia), Gregg B. Morin(University of British Columbia), Atsushi Nakanishi(Takeda (Japan)), Damian Yap(BC Cancer Agency), Aiko Murai(Takeda (Japan)), Ryujiro Hara(Fujirebio (Japan)), Hirokazu Tozaki(Takeda (Japan)), Daisuke Morishita(Unknown), Satoshi Sasaki(The University of Tokyo), Esther Kong(BC Cancer Agency), Momoko Ohori(Takeda (Japan)), Mari Ogasawara-Shimizu(Takeda (Japan)), Misa Iwatani(Takeda (Japan)), Jamie Rosner(University of British Columbia), Karey Shumansky(Canadian Centre for Applied Research in Cancer Control), Tomohiro Kawamoto(Takeda (Japan)), Shinsuke Araki(Takeda (Japan)), Christopher S. Hughes(Dalhousie University), Masaya Sano(Takeda (Japan)), Yusuke Nakayama(PaxVax (United States)), Toshiyuki Nomura(Mitsubishi Group (Japan)), T. Miyazaki(Takeda (Japan)), Siwei Cheng(Canada's Michael Smith Genome Sciences Centre), Arusha Oloumi(École Nationale Supérieure de Chimie de Montpellier), Steven McKinney(BC Cancer Agency), Shoichi Nakao(Takeda (Japan)), Osamu Nakanishi(Centerforce)
Nature Communications
February 13, 2017
Cited by 139


Related Papers